Highlights Novonesis A/S

Equities

NSIS B

DK0060336014

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:49 2024-05-15 am EDT			5-day change	1st Jan Change
426.5 ^DKK	+1.43%		+1.94%	+14.93%

May. 10	NOVONESIS : Key segments outperform in average Q1 24 showing
May. 03	Transcript : Novozymes A/S, Q1 2024 Sales/ Trading Statement Call, May 03, 2024

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NOVONESIS : Key segments outperform in average Q1 24 showing	May. 10
Novonesis Provides Sales Guidance for the Year 2024	May. 03	CI
Final dividend	Apr. 30	FA
Novozymes A/S Approves Dividend for the Last Four Months Ended December 31, 2023	Apr. 30	CI
Novozymes A/S Proposes Dividend for the Last Four Months Ended December 31, 2023	Apr. 08	CI
Novonensis expects 2024 adjusted EBITDA margin of 35%	Mar. 21	RE
Novonesis Provides Earnings Guidance for the Year 2024	Mar. 21	CI
Biotalys, Novonesis Sign Deal to Advance Biofungicide Candidate Development	Mar. 18	MT
Biotalys and Novonesis Announces Manufacturing and Commercialization Partnership for EVOCA NG	Mar. 18	CI
FMC Partners With Novonesis in Canada for Biosolution Products	Mar. 12	MT
Novonesis to Unveil Fit-for-Food Mood-Support Probiotic at Natural Product Expo West	Mar. 07	CI
Novo Nordisk's controlling shareholder plans to invest about $35 billion by 2030	Feb. 12	RE
Novozymes A/S Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 08	CI
NOVOZYMES : Q4 23: destocking noise offsets recovery in other key segments	Feb. 08
Novozymes, Chr. Hansen Complete Merger Settlement	Feb. 02	MT
Novozymes Completes Merger with Chr. Hansen After Securing Final Registration, Issuing B Shares	Jan. 29	MT
Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S.	Jan. 28	CI
Novozymes, Chr. Hansen’s Proposed Merger Secures All Regulatory Approvals	Jan. 26	MT
Novozymes, Chr. Hansen Merger Wins Korean Regulatory Nod	Dec. 20	MT
Celadon Pharma raises GBP2.0 million via placing	Dec. 12	AN

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

NOVONESIS : Key segments outperform in average Q1 24 showing

May 10, 2024 at 12:32 pm EDT